Contrast Enhanced Ultrasound in Neurosurgery to Improve Glioma Visualization and Border Demarcation
Part of paid clinical trials in Aurora, Colorado.
- Sponsor
- University of Colorado, Denver
- Study ID
- NCT07050836
- Phase
- EARLY_PHASE1
- Status
- Recruiting
Conditions
- Glioma
- Glioma (Any Grade) in the Brain
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 95 Years
- Healthy Volunteers
- Not accepted
Interventions
- Definity contrast during ultrasound — COMBINATION_PRODUCTDefinity contrast injection given just prior to brain tumor surgery. Contrast enhanced ultrasound during brain tumor surgical resection to aid in brain tumor visualization.
Study Details
This study plans to learn more about using contrast enhanced ultrasound (CEUS) in brain tumor surgery. The goal of glioma brain tumor surgery is to remove as much of the glioma as possible. Tumor tissue that is close to normal brain tissue can look very similar. This can make it difficult for the surgeon to remove all the tumor. In this study, we hope to learn if using CEUS during brain tumor surgery will allow the brain surgeon to better see and remove all the tumor tissue.
Key Dates
- Start date
- Dec 5, 2025
- Status verified
- Feb 2026
- Primary completion
- Dec 31, 2026
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: Brain tumor surgery with Definity contrast and Contrast Enhanced Ultrasound
Primary Outcome Measure
Primary Objective [ Time Frame: Up to 3 days ]
Central Contacts
- Jen Maitlen, BSN303-724-1995
- Terra Ornelas, BSN303-724-7970
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Colorado Anschutz Medical Campus | Aurora | Colorado | 80045 | D. Ryan Ormond, MD PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Aurora, CO
By condition
By specialty
By research site
Related Studies
- SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)PHASE3 · Recruiting · Nuvation Bio Inc. · Birmingham, Alabama
- A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.PHASE1 · Recruiting · Pfizer · Fayetteville, Arkansas
- A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid TumorsPHASE1 · Recruiting · Nested Therapeutics, Inc · San Francisco, California
- Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid TumorsRecruiting · Memorial Sloan Kettering Cancer Center · New York, New York